Found 23 matching trials
Fenofibrate and Pharmacogenetic Impact in Dyslipidemia N/A The purpose of the study is to learn whether genetics plays a role in predi...
Show More Location
University of Minnesota
Learn More & Join Trial
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) PHASE2 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Location
Arizona Liver Health
Learn More & Join Trial
Fenofibrate for Patients With COVID-19 Requiring Hospitalization PHASE3 This is an open-label run-in followed by a randomized, double-blind drug tr...
Show More Location
Barzilai Medical Center
Learn More & Join Trial
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ PHASE4 This was a 24-month, open-label extension study that followed an 8-week dou...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) PHASE3 The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Show More Location
Amarin Investigational Site
Learn More & Join Trial
Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions NA The study was conducted as an open-label, balanced, randomized, two-treatme...
Show More Location
Multiple Locations
Learn More & Join Trial
Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions NA The objective of this study was to compare the single-dose relative bioavai...
Show More Location
MDS Pharma Services
Learn More & Join Trial
Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate) PHASE1 This study will evaluate the bioequivalence of 105 mg fenofibric acid table...
Show More Location
Multiple Locations
Learn More & Join Trial
The DIAMOND® for the Treatment of Type 2 Diabetes NA Study to evaluate the efficacy of gastric stimulation (GCM) using the DIAMO...
Show More Location
Epworth Research Institute
Learn More & Join Trial
A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. PHASE2 This study is a double-blind randomized, placebo-controlled, parallel-group...
Show More Learn More & Join Trial